Ether lipid-nucleoside covalent conjugates
CA 2085354 C · Owner: Piantadosi, Claude · Inventors: Kucera, Louis S.; Piantadosi, Claude; Marasco, Canio J. Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Ether lipid nucleoside covalent conjugates and derivatives thereof are disclosed, along with pharmaceutical compositions containing the same and methods of using the same to combat HIV-1 infections. Illustrative are 3'-Azido-3'-deoxythymidine- 5'-monophosphate-D,L-3 octadecanamido-2-ethoxypropane and 3'-Azido-3'deoxythymidine-5' butyrate-y-N,N,N-trimethyl-ammonium-.beta.-(1-phospho-2-ethoxy-3-hexadecylozypropane).
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 1991 and granted August 27, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 14, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.